Cargando…
Biosynthesis of a VLP-type nanocarrier specific to cancer cells using the BEVS expression system for targeted drug delivery
OBJECTIVE: Canine parvovirus (CPV) is a small virus without an envelope that consists of three viral proteins including VP1, VP2, and VP3. Exclusively, the VP2 can form a typically CPV-sized virus-like particle (CPV-VLP) that can be used as a biological nanocarrier for diagnostic and therapeutic pur...
Autores principales: | Hashemzadeh, Mohammad Sadegh, Gharari, Nariman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9932404/ https://www.ncbi.nlm.nih.gov/pubmed/36795253 http://dx.doi.org/10.1186/s43141-023-00479-9 |
Ejemplares similares
-
Correction: Biosynthesis of a VLP-type nanocarrier specifc to cancer cells using the BEVS expression system for targeted drug delivery
por: Hashemzadeh, Mohammad Sadegh, et al.
Publicado: (2023) -
To Bev or Not to Bev during Ovarian Cancer Maintenance Therapy?
por: Sznurkowski, Jacek Jan
Publicado: (2023) -
Targeted Delivery of Protein Drugs by Nanocarriers
por: Solaro, Roberto, et al.
Publicado: (2010) -
Comments on machines for the energy range 2-BeV to 10-Bev
por: Midwestern Univ. Res. Ass.
Publicado: (1954) -
Polyester dendrimers: a versatile nanocarrier for target specific drug delivery
por: Aravind, A, et al.
Publicado: (2012)